Editas Medicine Inc (EDIT)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Katrine S. Bosley
Employees:
133
11 HURLEY ST., CAMBRIDGE, MA 02141
617-401-9000

Editas Medicine, Inc. engages in the development and commercialization of genome editting technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.^ ^ ^

Data derived from most recent annual or quarterly report
Market Cap 755.079 Million Shares Outstanding68.519 Million Avg 30-day Volume 1.784 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.67
Price to Revenue70.2824 Debt to Equity0.0 EBITDA-189.791 Million
Price to Book Value3.2427 Operating Margin-756.1306 Enterprise Value1.175 Billion
Current Ratio10.821 EPS Growth-0.429 Quick Ratio10.667
1 Yr BETA 2.2304 52-week High/Low 73.03 / 9.71 Profit Margin-753.6095
Operating Cash Flow Growth8.9189 Altman Z-Score6.8298 Free Cash Flow to Firm -187.116 Million
Earnings Report2022-08-03
View SEC Filings from EDIT instead.

View recent insider trading info

Funds Holding EDIT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EDIT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.6 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EATON BRUCE EVP, CHIEF BUSINESS OFFICER

66,544 2022-05-09 8

MULLEN JAMES C CEO

170,989 2022-04-14 6

ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER

84,194 2022-03-03 6

SHEARMAN MARK S EVP, CHIEF SCIENTIFIC OFFICER

166,892 2022-02-10 4

MICHAELS LISA ANNE EVP/CHIEF MEDICAL OFFICER

  • Officer
22,675 2021-12-22 2

CONNAUGHTON BERNADETTE

  • Director
0 2021-10-26 2

REEVE EMMA

  • Director
0 2021-09-03 2

VAISHNAW AKSHAY

  • Director
11,538 2021-06-03 1

HIRSCH ANDREW

  • Director
11,538 2021-06-03 1

HOPFIELD JESSICA

  • Director
11,538 2021-06-03 1

SCADDEN DAVID

  • Director
11,538 2021-06-03 1

CHATTERJEE MEETA

  • Director
11,538 2021-06-03 1

COLLINS CYNTHIA CEO

  • Officer
43,760 2021-02-09 0

ALBRIGHT CHARLES EVP/CHIEF SCIENTIFIC OFFICER

  • Officer
24,907 2020-12-15 0

ABRAMS JUDITH R CHIEF MEDICAL OFFICER

  • Officer
25,000 2019-10-28 0

MYER VICKESH CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-03-18 0

EK ERIC INTERIM CFO

  • Officer
0 2019-03-01 0

HACK ANDREW A. F. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-02-04 0

BOSLEY KATRINE PRESIDENT AND CEO

  • Officer
  • Director
1,204,966 2019-01-08 0

NIKOLIC BORIS

  • Director
0 2018-06-15 0

COX GERALD FRANK CHIEF MEDICAL OFFICER

  • Officer
0 2018-02-07 0

COLE DOUGLAS G.

  • Director
3,171 2017-08-17 0

MENDLEIN JOHN

  • Director
0 2017-06-15 0

BORISY ALEXIS

  • Director
0 2017-06-15 0

BITTERMAN KEVIN

  • Director
0 2017-06-15 0

GLUCKSMANN ALEXANDRA CHIEF OPERATING OFFICER

  • Officer
117,788 2017-03-15 0

POLARIS VENTURE MANAGEMENT CO. VI, L.L.C.

POLARIS VENTURE PARTNERS VI, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND VI, L.P.

  • 10% Owner
3,797,144 2016-12-07 0

STARR KEVIN P

  • 10% Owner
3,906,176 2016-09-06 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
3,906,176 2016-08-16 0

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

AFEYAN NOUBAR

KANIA EDWIN M JR

  • 10% Owner
No longer subject to file 2016-08-11 0

FLYNN JAMES E

DEERFIELD MGMT III, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

DEERFIELD MGMT HIF, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2016-02-08 0

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES LP

VIKING GLOBAL EQUITIES II LP

VGE III PORTFOLIO LTD.

VIKING LONG FUND MASTER LTD.

VIKING LONG FUND GP LLC

  • 10% Owner
2,040,814 2016-02-08 0

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SUNDHEIM DANIEL S.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2016-02-08 0

BNG0, LLC

  • 10% Owner
No longer subject to file 2016-02-08 0

CHURCH GEORGE

  • 10% Owner
480,769 2016-02-02 0

ZHANG FENG

  • 10% Owner
480,769 2016-02-02 0

LIU DAVID R.

  • 10% Owner
480,769 2016-02-02 0

JOUNG J. KEITH

  • 10% Owner
480,769 2016-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

EATON BRUCE EVP, CHIEF BUSINESS OFFICER

2022-05-11 16:15:36 -0400 2022-05-09 S 297 $13.11 d 66,544 direct 9.8057 1.2026 9.8057 2 -0.8326 5

MULLEN JAMES C CEO

2022-04-18 16:15:11 -0400 2022-04-14 A 170,989 a 170,989 direct

EATON BRUCE EVP, CHIEF BUSINESS OFFICER

2022-04-04 16:30:15 -0400 2022-04-01 S 1,258 $19.64 d 66,841 direct -2.8529 -11.9528 -47.27 0.0 1 -50.664 26

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EDITAS MEDICINE INC EDIT 2022-05-20 22:15:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 21:45:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 21:15:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 20:45:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 20:15:05 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 19:45:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 19:15:04 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 18:45:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 18:15:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 17:45:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 17:15:03 UTC 0.2477 0.5723 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 16:45:04 UTC 0.2603 0.5597 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 16:15:03 UTC 0.2603 0.5597 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 15:45:03 UTC 0.2603 0.5597 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 15:15:03 UTC 0.2603 0.5597 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 14:45:03 UTC 0.5185 0.3015 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 14:15:04 UTC 0.5185 0.3015 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 13:45:03 UTC 0.5185 0.3015 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 13:15:03 UTC 0.5185 0.3015 1600000
EDITAS MEDICINE INC EDIT 2022-05-20 12:45:03 UTC 0.5185 0.3015 1600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund EDIT -134.0 shares, $-2657.22 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund EDIT -93.0 shares, $-1844.19 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund EDIT -154.0 shares, $-3053.82 2020-03-31 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund EDIT -1156.0 shares, $-48390.16 2021-07-31 N-PORT

Elevate your investments